Fusion Pharmaceuticals Inc.

Biological Products, (No Diagnostic Substances)·HAMILTON, A6

Financials

17 shown

Type	Period	Ended	Filed
10-Q	Q1 2024	3/31/24	5/7/24	→
10-K/A	FY 2023	12/31/23	4/12/24	→
10-K	FY 2023	12/31/23	3/20/24	→
10-Q	Q3 2023	9/30/23	11/7/23	→
10-Q	Q2 2023	6/30/23	8/8/23	→
10-Q	Q1 2023	3/31/23	5/11/23	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
5/7/24	Q2 FY2024	→
3/20/24	Q1 FY2024	→
11/7/23	Q4 FY2023	→
8/8/23	Q3 FY2023	→
5/11/23	Q2 FY2023	→
3/16/23	Q1 FY2023	→
↓

News (8-K)

34 shown

Filed	Type	Description
6/4/24	Delisting	Completion of Acquisition or Disposition of Assets	→
5/31/24	Other	Other Events	→
5/29/24	Reg FD	Submission of Matters to a Vote of Security Holders	→
5/10/24	Other	Other Events	→
5/2/24	Other	Other Events	→
4/23/24	Other	Other Events	→
↓

Prospectuses & Registrations

19 shown

Filed	Form	Description
6/4/24	S-8 POS	S-8 POS	→
6/4/24	S-8 POS	S-8 POS	→
6/4/24	S-8 POS	S-8 POS	→
6/4/24	S-8 POS	S-8 POS	→
6/4/24	S-8 POS	S-8 POS	→
3/20/24	S-8	S-8	→
↓

Filing History(293 filings)

TypeDateAccessionPeriodSize

15-12G

Jun 17, 2024

0001193125-24-16198715-12G

—

10.9 KB

EFFECT

Jun 7, 2024

9999999995-24-001778

—

1.7 KB

EFFECT

Jun 7, 2024

9999999995-24-001777

—

1.7 KB

EFFECT

Jun 7, 2024

9999999995-24-001776

—

1.7 KB

25-NSE

Jun 5, 2024

0001354457-24-000389

—

2.9 KB

Jun 4, 2024

0000950170-24-0689124

Jun 4, 2024

6.9 KB

Jun 4, 2024

0000950170-24-0689064

Jun 4, 2024

16.1 KB

Jun 4, 2024

0000950170-24-0689054

Jun 4, 2024

28.9 KB

Jun 4, 2024

0000950170-24-0689044

Jun 4, 2024

14.8 KB

Jun 4, 2024

0000950170-24-0689014

Jun 4, 2024

12.8 KB

Jun 4, 2024

0000950170-24-0688974

Jun 4, 2024

17.3 KB

Jun 4, 2024

0000950170-24-0688934

Jun 4, 2024

24.9 KB

Jun 4, 2024

0000950170-24-0688924

Jun 4, 2024

6.9 KB

Jun 4, 2024

0000950170-24-0688894

Jun 4, 2024

11.8 KB

Jun 4, 2024

0000950170-24-0688884

Jun 4, 2024

6.9 KB

Jun 4, 2024

0000950170-24-0688854

Jun 4, 2024

12.8 KB

Jun 4, 2024

0000950170-24-0688814

Jun 4, 2024

34.8 KB

Jun 4, 2024

0000950170-24-0688794

Jun 4, 2024

15.2 KB

Jun 4, 2024

0000950170-24-0688674

Jun 4, 2024

12.8 KB

POS AM

Jun 4, 2024

0001193125-24-154320POS AM

—

24.7 KB

POS AM

Jun 4, 2024

0001193125-24-154317POS AM

—

24.7 KB

POS AM

Jun 4, 2024

0001193125-24-154314POS AM

—

24.7 KB

S-8 POS

Jun 4, 2024

0001193125-24-154310S-8 POS

—

26.5 KB

S-8 POS

Jun 4, 2024

0001193125-24-154305S-8 POS

—

26.5 KB

S-8 POS

Jun 4, 2024

0001193125-24-154298S-8 POS

—

26.5 KB

25 filings shown

Filed	Form	Description
5/10/24	DEFA14A	DEFA14A	→
5/2/24	DEFA14A	DEFA14A	→
4/25/24	DEFM14A	DEFM14A	→
4/23/24	DEFA14A	DEFA14A	→
4/10/24	PREM14A	PREM14A	→
3/19/24	DEFA14A	DEFA14A	→
↓

Fusion Pharmaceuticals Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(293 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
6/17/24	15-12G	15-12G	→
6/7/24	EFFECT	EFFECT	→
6/7/24	EFFECT	EFFECT	→
6/7/24	EFFECT	EFFECT	→
6/5/24	25-NSE	25-NSE	→
6/4/24	POS AM	POS AM	→
↓